default author photo

Yu-ning Wang

Ningxia Medical University

692 Shengli St.

Yinchuan, Ningxia 750004

China

Government of the People's Republic of China - Department of Urinary Surgery

800 Xiangyin Rd

Yangpu Qu

China

SCHOLARLY PAPERS

1

DOWNLOADS

117

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Gankyrin is a Novel Biomarker for Disease Progression and Prognosis of Patients with Renal Cell Carcinoma

, EBioMedicine, Volume 39, January 2019, Pages 255-264, https://doi.org/10.1016/j.ebiom.2018.12.011
Number of pages: 48 Posted: 06 Nov 2018
Chao Wang, Yan Li, Xiang-min Zhang, Jie Ma, Hai Huang, Yu-ning Wang, Tian-yu Hong, Jing Zhang, Xiu-wu Pan, Chuan-min Chu, Jing-cun Zheng, Ning Jiang, Chuan-yi Hu, Xiao-jing Ma and Xin-gang Cui
Government of the People's Republic of China - Department of Urinary Surgery, Ningxia Medical University, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Shanghai Jiao Tong University (SJTU) - Department of Urinary Surgery, Ningxia Medical University, Ningxia Medical University, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Naval Medical University (SMMU), Government of the People's Republic of China - Department of Urinary Surgery, Government of the People's Republic of China - Department of Urinary Surgery, Cornell University - Department of Microbiology and Immunology and Government of the People's Republic of China - Department of Urinary Surgery
Downloads 117 (608,822)

Abstract:

Loading...

Renal cell carcinoma; gankyrin; prognosis; disease progression